Centenial Surgical Suture Q1 Results: Net profit turns positive at ₹73.59 lakh
Centenial Surgical Suture Ltd reported a Q1FY26 standalone net profit of ₹73.59 lakh, reversing a loss of ₹3.99 lakh in Q1FY25. Revenue grew 18.7% YoY to ₹1,535.53 lakh. The board approved the results on August 14, 2026.
*this image is generated using AI for illustrative purposes only.
Centenial Surgical Suture Ltd Centenial Surgical Suture Ltd returned to profitability in the first quarter of FY26, reporting a standalone net profit of ₹73.59 lakh for the period ended June 30, 2026. This marks a significant turnaround from the net loss of ₹3.99 lakh incurred during the same quarter in the previous fiscal year.
The company’s total income from operations expanded by 18.7% year-on-year to ₹1,535.53 lakh, up from ₹1,293.80 lakh in Q1FY25. The improvement in the top line contributed to a pre-tax profit of ₹98.23 lakh, compared to a pre-tax loss of ₹3.99 lakh in the corresponding quarter of FY25.
Financial Performance
The Board of Directors approved the unaudited standalone financial results in its meeting held on August 14, 2026. The results were reviewed and recommended by the Audit Committee prior to board approval.
| Metric | Q1FY26 (Unaudited) | Q1FY25 (Unaudited) | Change |
|---|---|---|---|
| Total Income from Operations | ₹1,535.53 lakh | ₹1,293.80 lakh | +18.7% |
| Net Profit / (Loss) Before Tax | ₹98.23 lakh | (₹3.99 lakh) | Turnaround |
| Net Profit / (Loss) After Tax | ₹73.59 lakh | (₹3.99 lakh) | Turnaround |
| Basic EPS (₹) | 2.09 | (0.19) | Positive |
| Diluted EPS (₹) | 2.09 | (0.19) | Positive |
For the full year ended March 31, 2026, the company reported a net loss of ₹220.46 lakh, down from a loss of ₹208.33 lakh in Q4FY26 alone. The equity share capital remained unchanged at ₹364.83 lakh.
What the Numbers Show
The shift from a net loss to a net profit in Q1FY26 indicates an operational recovery for Centenial Surgical Suture. With total income rising nearly 19% while moving to a positive bottom line, the company appears to have improved its cost efficiency or product mix compared to the prior year period. The basic earnings per share turned positive at ₹2.09, reflecting the return to profitability for shareholders after a negative EPS of ₹0.19 in Q1FY25.
Historical Stock Returns for Centenial Surgical Suture
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.77% | +13.37% | +9.75% | +7.32% | -39.09% | +77.53% |
What specific operational strategies or cost-cutting measures drove the 18.7% revenue growth and margin expansion in Q1FY26?
Can the company sustain this profitability trajectory given the full-year FY26 net loss of ₹220.46 lakh, or was Q1 a seasonal anomaly?
How does Centenial Surgical Suture plan to allocate its improved cash flows between debt reduction, R&D, or market expansion in the coming quarters?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
